ENTITY
Ascentage Pharma Group Corp

Ascentage Pharma Group Corp (6855 HK)

33
Analysis
Health CareChina
Ascentage Pharma Group International operates as a clinical-stage biotechnology company. The Company develops novel therapies for cancers, hepatitis B virus, age-related diseases, and more. Ascentage Pharma Group International conducts businesses in China, the United States, and other countries.
more
Refresh
22 Jun 2019 12:52

ECM Weekly (22 Jun 2019) -  Alibaba, Budweiser Brewing Co, Ascentage, CIMC Vehicle, Impro Precision

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
19 Jun 2019 13:02

Ascentage Pharma (亚盛医药) IPO: Updates and Thoughts on HQP1351 (3rd Gen Bcr-Abl TKI)

Ascentage Pharma is pre-marketing the USD 200 - 300 million IPO to list in Hong Kong. In our previous insight, we highlight the company's key...

Logo
736 Views
Share
07 Dec 2018 15:32

Ascentage Pharma (亚盛医药) IPO: Too Early for an IPO

Ascentage Pharma, a China-based biotech company, filed an application to list on the Hong Kong Stock Exchange. In this insight, we will cover the...

Logo
1k Views
Share
x